Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal Acetate plus Meloxicam for On-Demand Contraception
NCT03354117Phase 1Completed
- Sponsor
- Stanford University
- Start
- Mar 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of meloxicam in contraception, sponsored by Stanford University. Primary endpoint: ovulatory disruption at 8 weeks. Started Mar 2018; status: completed.
02
Drugs
meloxicam
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03354117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03354117.